Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15821556 | 0.80 | ALDH1A1 (0.48) | TSHRTRPA1ALDH1A1CES2CES1 | |
| SCHEMBL131361 | 0.78 | ALDH1A1 (0.67) | TSHRTRPA1ALDH1A1CES2CES1 | |
| SCHEMBL8505290 | 0.76 | ALDH1A1 (0.43) | TSHRTRPA1ALDH1A1CES2CES1 | |
| SCHEMBL12182788 | 0.76 | TSHR (0.43) | TSHRTRPA1ALDH1A1CES2CES1 | |
| SCHEMBL8587970 | 0.76 | PLAU (0.52) | TSHRTRPA1ALDH1A1 | |
| SCHEMBL24423474 | 0.76 | NOS3 (0.52) | — | |
| SCHEMBL10035756 | 0.76 | NOS3 (0.50) | TSHRADRA2AADRA2BADRA2C | |
| Bromide SCHEMBL29980639 | 0.75 | ALDH1A1 (0.62) | TSHRTRPA1ALDH1A1CES2CES1 | |
| SCHEMBL8588836 | 0.72 | LPL (0.45) | CYP3A4P2RY6 | |
| SCHEMBL12108414 | 0.72 | CA2 (0.52) | TSHRALDH1A1CYP3A4P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109851523-B | Dimeric surfactant containing azobenzene group and application thereof | 江南大学 | 2020-11-06 | — | — | CN | claimed |
| CN-109851523-B | Dimeric surfactant containing azobenzene group and application thereof | 江南大学 | 2020-11-06 | — | — | CN | disclosed |
| CN-108837770-A | The four poly- surfactant worm-like micelle systems containing azobenzene group | 江南大学 | 2018-11-20 | — | — | CN | disclosed |
| US-8361908-B2 | Modified surface material, method for preparing same and uses thereof | UNIVERSITE PARIS 7-DENIS DIDEROT (FR) | 2013-01-29 | — | — | US | disclosed |
| US-20120015138-A1 | MODIFIED SURFACE MATERIAL, METHOD FOR PREPARING SAME AND USES THEREOF | ALCHIMEDICS (FR) | 2012-01-19 | — | — | US | disclosed |
| US-8053567-B2 | forming undercoatings on semiconductor by polymerizing monomers with diazonium salt which can electrochemical reduction having a polymerization initiator function; in situ free radical polymerization; stents, implants, prostheses; corrosion resistance | Universite Paris 7—Denis Diderot (FR) | 2011-11-08 | — | — | US | disclosed |
| EP-1778770-B1 | MODIFIED SURFACE MATERIAL, METHOD FOR PREPARING SAME AND USES THEREOF | UNIV PARIS 7 DENIS DIDEROT (FR) | 2011-11-02 | — | — | EP | disclosed |
| US-20080064783-A1 | Modified Surface Material, Method for Preparing Same and Uses Thereof | ALCHIMEDICS (FR) | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064783-A1 | Modified Surface Material, Method for Preparing Same and Uses Thereof | SOAT2, SOAT1, INMT | TSHR 4866/4885TRPA1 2241/4885ALDH1A1 461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.